HPD and metabolic disease: Nitisinone (NTBC) is a specific inhibitor of 4-hydroxyphenylpyruvate dioxygenase (4-HPPD), utilized in treating metabolic disorders such as hereditary type I tyrosinemia and alkaptonuria by reducing the accumulation of toxic metabolites.